Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

27.77
+1.786.85%
Post-market: 28.420.6502+2.34%19:59 EDT
Volume:26.51M
Turnover:721.36M
Market Cap:6.17B
PE:52.18
High:30.00
Open:24.50
Low:23.97
Close:25.99
Loading ...

Why Is HIMS Stock Dropping Today?

TIPRANKS
·
22 Feb

Analysts explain why Hims & Hers stock is crashing today

Investing.com
·
22 Feb

Top Midday Stories: UnitedHealth Under DOJ Investigation Over Medicare Billing Practices; Novo Nordisk Resolves Ozempic Shortage

MT Newswires Live
·
22 Feb

Hims & Hers Health Down Over 18%, on Pace for Largest Percent Decrease Since November 2024 -- Data Talk

Dow Jones
·
22 Feb

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

Blockhead
·
22 Feb

Hims & Hers Health Shares Tumble After Novo Nordisk Says Wegovy, Ozempic Shortage is Over

Dow Jones
·
22 Feb

BUZZ-Hims and Hers falls as US shortage of Novo's weight loss drug is resolved

Reuters
·
21 Feb

Stock Track | Hims & Hers Health Stock Plummets 25.76% as FDA Ends Ozempic, Wegovy Shortage

Stock Track
·
21 Feb

Hims & Hers Health's Q4 Revenue Likely to Be Above Estimates, Truist Says

MT Newswires Live
·
21 Feb

Novo Nordisk's Shortage of Ozempic, Wegovy Resolved

MT Newswires Live
·
21 Feb

Hims & Hers falls -19.1%

TIPRANKS
·
21 Feb

Hims & Hers Shares Down 24% After US FDA Says That Novo Nordisk's Weight-Loss Drug Shortage Is Resolved

THOMSON REUTERS
·
21 Feb

Hims & Hers Health Acquires California Peptide Facility

MT Newswires Live
·
21 Feb

Hims & Hers Health Shares Fall Pre-Bell as US FDA Says Ozempic, Wegovy Shortages Have Ended

MT Newswires Live
·
21 Feb

Novo’s Ozempic, Wegovy Shortage Ends, Threatening Copycats

Reuters
·
21 Feb

Hims & Hers Shares Down 19% After US FDA Says That Novo Nordisk's Weight-Loss Drug Shortage Is Resolved

THOMSON REUTERS
·
21 Feb

Hims & Hers Shares Down 6% Premarket After Co Acquires US-Based Peptide Facility

THOMSON REUTERS
·
21 Feb

BRIEF-Hims & Hers Acquires US-Based Peptide Facility

Reuters
·
21 Feb

Hims & Hers Acquires US-Based Peptide Facility

THOMSON REUTERS
·
21 Feb

Hims & Hers Acquires US-based Peptide Facility

Business Wire
·
21 Feb